Over the last few years there has been a surge of interest and media in using psychedelics as psychiatric drugs to “treat” so-called “mental illness.” Need we actually say that this is an insanely bad idea?
For example, psychiatrists have been demanding funds for research using LSD,psilocybin (magic mushroom), MDMA (Ecstasy), marijuana,ketamine and kratom.
Even if psychedelic drugs are administered to consenting subjects, such research demonstrates a fundamental disregard for human life because of the drugs’ mind-altering properties, born out by the psychiatric-intelligence community’s past research of LSD, psilocybin and amphetamines. Not only does psychedelic drug abuse endanger one’s health, but also one’s learning rate, attitudes, personality and overall mental acuity.
Thirty-two million people in the US are reported users of psychedelic drugs, while reports of riots, violence, suicide, and psychotic behavior are rising.
Apparently enough time has passed that the public has forgotten what happened when psychedelics gained notoriety in the 1960s, when LSD pushed by psychiatrists spread into society as a recreational drug and started destroying lives with induced psychosis. Even the psychiatric billing bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM), lists various forms of “hallucinogen intoxication” as a mental disorder so that psychiatrists can make a buck from “treating” it.
The long history of psychiatry’s attempts to promote psychedelics should give us additional clues to their harm. In the last 150 years, psychiatry has been unable to justify any cures using psychedelics. In the 1840’s French psychiatrist Jacques-Joseph Moreau promoted marijuana as a medicine. Psychedelic drugs were studied for mental health conditions in the 1950’s and 1960’s. The Multidisciplinary Association for Psychedelic Studies (MAPS) was founded in 1986 by Rick Doblin specifically to promote marijuana and psychedelics as “medicines” after his experiments using psychedelic drugs to catalyze religious experiences. In 1992, Australian psychiatrists called for heroin, cocaine and marijuana to be sold legally in liquor stores. Today, psychiatrists are embracing all things marijuana because they are getting so many patients with marijuana-related problems such as addiction and psychosis.
A surge of interest in “repurposing” psychiatric drugs for other uses has also surfaced. Researchers at Washington University School of Medicine in St. Louis announced they have launched a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. The trial is investigating whether the antidepressant fluvoxamine (Luvox)–a drug linked to the Columbine High School shooting in 1999–can be repurposed for COVID-19.
The facts show psychedelics can trigger rage, violence, aggression, and precipitate various mental disorders. Whether given in a clinical setting or illegally abused, the drugs can have harmful outcomes and have no use in the mental health field.
Contact your local, state and federal officials. Let them know what you think about this, and encourage them not to fund psychedelic research.
